hotspot -WSS

hotspot

author：Wikipedia 2025-09-28 16:34:57 - browse：6456

WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Bring on the sabbaticals for nurses

entertainment

hotspot

WSS

Cassava Sciences’ Alzheimer’s clinical trials should be halted

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

'Patient friction coefficient' can gauge a clinical trial's patient burden

STAT Summit: Ending the crisis of Black deaths in the U.S.

Roivant's CEO is a star, but biotech's black hole persists

Smaller biotechs seek to piggyback on weight loss drug boom

leisure time

hotspot

knowledge

Apple is now the first public company to be valued at $3 trillion

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Walensky prepares to leave CDC — and Congress — behind

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Psychedelics group wrestles with new pharma identity

What Kate Middleton's cancer revelation might teach the world

Supreme Court strikes down use of affirmative action

With Wegovy coverage, Medicare patients may face high costs

Hollywood unions extend contract negotiations for actors

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

knowledge

Diabetes management: Digital health tools fall short, study says

Pfizer, Moderna say biotech, pharma drug development is a sprint

Erich Jarvis studies song birds to learn about human stuttering

CZI to create biohub to build anti

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

STAT Readout Newsletter: Biotech news today

knowledge

entertainment

hotspot

Wikipedia